EP Patent

EP2934514A4 — TRANSTHYRETIN STABILIZERS AND THEIR USE FOR INHIBITING TRANSTHYRETIN AMYLOSE AND PROTEIN-PROTEIN INTERACTIONS

Assigned to Leland Stanford Junior University · Expires 2016-06-08 · 10y expired

What this patent protects

Patent listed against acoramidis-hydrochloride.

Drugs covered by this patent

acoramidis-hydrochloride (ACORAMIDIS HYDROCHLORIDE)

Patent Metadata

Patent number: EP2934514A4
Jurisdiction: EP
Classification: —
Expires: 2016-06-08
Drug substance claim: No
Drug product claim: No
Assignee: Leland Stanford Junior University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.